Prevalence of human papillomavirus genotype among Moroccan women during a local screening program

Journal of Infection in Developing Countries

Volumn 4, Issue 11, 2010, Pages 732-739

  Alhamany, Zaitouna ^a,c   El Mzibri, Mohammed ^b   Kharbach, Aïcha ^a   Malihy, Abderrahmane ^a   Abouqal, Redouane ^c   Jaddi, Hassan ^b   Benomar, Ali ^c   Attaleb, Mohammed ^b   Lamalmi, Najat ^a   Cherradi, Nadia ^a  

^a IBN SINA HOSPITAL   (Morocco)

^b CENTRE NATIONAL DE L ENERGIE DES SCIENCES TECHNIQUES NUCLEAIRES   (Morocco)

^c MOHAMMED V UNIVERSITY   (Morocco)

Author keywords

Cervical cancer; HPV; Molecular hybridization; Morocco; PCR

Indexed keywords

VIRUS DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CONDYLOMA ACUMINATUM; CONTROLLED STUDY; CYTOPATHOLOGY; FEMALE; GENE AMPLIFICATION; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 45; HYGIENE; MAJOR CLINICAL STUDY; MIXED INFECTION; MOROCCO; ORAL CONTRACEPTION; PAPANICOLAOU TEST; PREVALENCE; RISK FACTOR; SCREENING; SOCIAL STATUS; UTERINE CERVICITIS; UTERINE CERVIX CYTOLOGY; WART VIRUS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; PAPILLOMAVIRIDAE;

EID: 78650371704     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.781     Document Type: Article

References (34)

1. Roberts CC, Tadesse AS, Sands J, Halvorsen T, Schofield TL, Dalen A, Skjeldestad FE, Jansen KU (2006) Detection of HPV in Norwegian cervical biopsy specimens with type-specific PCR and reverse line blot assays. J Clin Virol 36: 277-82.
2. Amrani M, Lalaoui K, El Mzibri M, Lazo P and Belabbas MA (2003) Molecular detection of human papillomavirus in 594 uterine cervix samples from Moroccan women (147 biopsies and 447 swabs). J Clin Virol 27: 286-95.
3. IARC. International Agency on Research on Cancer (1995) Monograph on cancer, Human papillomavirus. Vol: 64. World Health Organization.
4. Zur Hausen H (2000) Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 92: 690-98.
5. Woodman CB, Collins SI, Young LS (2007) The natural history of cervical HPV infection: unresolved issues. Nat Rev Cancer 7: 11-22.
6. Wei YC, Chou YS, Chu TY (2007) Detection and typing of minimal human papillomavirus DNA in plasma. Int J Gynaecol Obstet 96: 112-16.
7. Muñoz N, Bosch FX, De Sanjosé S, Herrero R, Castellsagué X, Shah KV Snijders PJF and Meijer CJLM (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348: 518-27.
8. Kay P, Soeters R, Nevin J, Denny L, Dehaeck CMC, Williamson AL (2003) High prevalence of HPV 16 in South African women with cancer of the cervix and cervical intraepithelial neoplasia. J Med Virol 71: 265-73.
9. Andersson S, Mints M, Sällström J, Wilander E (2005) The relative distribution of oncogenic types of human papillomavirus in benign, pre-malignant and malignant cervical biopsies. A study with human papillomavirus deoxyribonucleic acid sequence analysis. Cancer Detect Prev 29: 37-41.
10. Brestovac B, Harnett GB, Smith DW, Shellam GR, Frost FA. (2005) Human papillomavirus genotypes and their association with cervical neoplasia in a cohort of Western Australian women. J Med Virol 76: 106-10.
11. Lazo PA (1999) The molecular genetics of cervical carcinoma. Br J Cancer 80: 2008-18.
12. Cuzick J, Clavel C, Petry KU, Meijer CJLM, Hoyer H, Ratnam S,Szarewski A, Birembaut P, Kulasingam S, Sasieni P and Iftner T (2006) Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer 119: 1095-101.
13. Cox T and Suzick J (2006) HPV DNA testing in cervical cancer screening: From evidence to policies. Gynaecologic Oncology 103: 8-11.
14. Cuzick J, Szarewski A, Cubie H, Hulman G, Kitchener H, Luesley D, McGoogan E, Menon U, Terry G, Edwards R, Brooks C, Desai M, Gie C, Ho L, Jacobs I, Pickles C, Sasieni P (2003) Management of women who test positive for high-risk types of human papillomavirus: the HART study. Lancet 362: 1871-76.
15. A.N.A.E.S (1999) Conduite à tenir devant un frottis cervico-utérin anormal. Ann Pathol 19: 57-75.
16. Smith JHF (2002) Review Bethesda 2001. Cytopathology 13: 4-10.
17. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular Cloning: A laboratory manual. Cold Spring Harbor: Cold Spring Harbor Laboratory Press 1659 p.
18. Husnjak K, Grce M, Magdić L, Pavelić K (2000) Comparison of five different polymerase chain reaction methods for detection of human papillomavirus in cervical cell specimens. J Virol Methods 88: 125-34.
19. Bauer HM, Ting Y, Greer CE, Chambers JC, Tashiro JC, Chimera CL, Reingold A and Manos M (1991) Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA 256: 472-77.
20. Parkin DM, Pisani P, Ferlay J (1999) Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 80: 827-41.
21. Ghaffari SR, Sabokbar T, Mollahajian H, Dastan J, Ramezanzadeh F Ensani F, Yarandi F, Mousavi-Jarrahi A, Mohagheghi MA, Moradi A (2006) Prevalence of Human Papillomavirus Genotype in Women with Normal and Abnormal Cervical Cytology in Iran. Asian Pacific J Cancer Prev 7: 529-32.
22. Clifford GM, Gallus S, Herrero R, Muñoz N, Snijders PJ, Vaccarella S, Anh PT, Ferreccio C, Hieu NT, Matos E, Molano M, Rajkumar R, Ronco G, de Sanjosé S, Shin HR, Sukvirach S, Thomas JO, Tunsakul S, Meijer CJ and Franceschi S (2005) Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 366: 991-98.
23. Kumar K, Venkateswaran K, Neerja B, Alka K, Kusum V (2007) Comparative evaluation of smear cytology & hybrid capture II for the diagnosis of cervical cancer. Indian. J Med Res 126: 39-44.
24. Núñez-Troconis J, Delgado M, González J, Mindiola R, Velásquez J, Conde B, Whitby D, Munroe DJ (2009) Prevalence and risk factors of human papillomavirus infection in asymptomatic women in a Venezuelan urban area. Invest Clin 50: 203-12
25. Hammouda D, Muñoz N, Herrero R (2005) Cervical Carcinoma in Algiers, Algeria: Human Papillomavirus and Lifestyle Risk Factors. Int J Cancer 113: 483-89.
26. Meftah El Khair M, El Mzibri M, Ait Mhand R, Benider A, Benchekroun N, El Fahime M, Benchekroun MN and Ennaji MM (2009) Molecular detection and genotyping of human papillomavirus in cervical carcinoma biopsies in an area of high incidence of cancer from Moroccan women. J Med Virol 81: 678-84.
27. Trottier H, Mahmud S, Costa MC, Sobrinho JP, Franco ED, Rohan TE, Ferenczy A, Villa LL and Franco EL (2006) Human Papillomavirus Infections with Multiple Types and Risk of Cervical Neoplasia. Cancer Epidemiol Biomarkers Prev 15: 1274-79.
28. Van Der Graaf Y, Molijn A, Doornewaard H, Quint W, van Doorn LJ and Van Den Tweel J (2002) Human papillomavirus and the long-term risk of cervical neoplasia. Am J Epidemiol 156: 158-64.
29. Herrero R, Castle PE, Schiffman M, Bratti MC, Hildesheim A, Morales J, Alfaro M, Sherman ME, Wacholder S, Chen S, Rodriguez AC and Burk RD (2005) Epidemiologic profile of type specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. J Infect Dis 191: 1796- 807.
30. Fife KH, Cramer HM, Schroeder JM and Brown DR (2001) Detection of multiple human papillomavirus types in the lower genital tract correlates with cervical dysplasia. J Med Virol 64: 550-59.
31. Castellsague X and Muñoz N (2003) Cofactors in human papillomavirus carcinogenesis-role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr 31: 20-28.
32. Franceschi S, Rajkumar T, Vaccarella S, Gajalakshmi V, Sharmila A, Snijders PJ, Muñoz N, Meijer CJ and Herrero R (2003) Human papillomavirus and risk factors for cervical cancer in Chennai, India: A case-control study. Int J Cancer 107: 127-33.
33. Murthy NS and Matthew A (2002) Risk factors for precancerous lesions of the cervix. Eur J Cancer Prev 9: 5-14.
34. Tay SK and Tay KJ (2004) Passive cigarette smoking is a risk factor in cervical neoplasia. Gynecol Oncol 93: 116-20